J&J analyst day tries to steer focus to drug business as talc baby powder comes under fire

Johnson & Johnson's pharmaceutical business will take the spotlight Wednesday at the company's analyst day as the company shares its plans for the next few years and tries to allay investors' concerns over talc-based baby powder.